252 related articles for article (PubMed ID: 27651465)
21. Safety and Effectiveness of Omnitrope®, a Biosimilar Recombinant Human Growth Hormone: More Than 10 Years' Experience from the PATRO Children Study.
Pfäffle R; Bidlingmaier M; Kreitschmann-Andermahr I; Land C; Partsch CJ; Schwab KO; Sommer H; Backeljauw P; Kanumakala S; Loche S; Zouater H; Strasburger CJ
Horm Res Paediatr; 2020; 93(3):154-163. PubMed ID: 32814319
[TBL] [Abstract][Full Text] [Related]
22. Observed and predicted total pubertal growth during treatment with growth hormone in adolescents with idiopathic growth hormone deficiency, Turner syndrome, short stature, born small for gestational age and idiopathic short stature: KIGS analysis and review.
Ranke MB; Lindberg A
Horm Res Paediatr; 2011; 75(6):423-32. PubMed ID: 21358173
[TBL] [Abstract][Full Text] [Related]
23. Long-Acting C-Terminal Peptide-Modified hGH (MOD-4023): Results of a Safety and Dose-Finding Study in GHD Children.
Zelinska N; Iotova V; Skorodok J; Malievsky O; Peterkova V; Samsonova L; Rosenfeld RG; Zadik Z; Jaron-Mendelson M; Koren R; Amitzi L; Raduk D; Hershkovitz O; Hart G
J Clin Endocrinol Metab; 2017 May; 102(5):1578-1587. PubMed ID: 28323965
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness and Overall Safety of NutropinAq
Coutant R; Bosch Muñoz J; Dumitrescu CP; Schnabel D; Sert C; Perrot V; Dattani M
Front Endocrinol (Lausanne); 2021; 12():676083. PubMed ID: 34113318
[TBL] [Abstract][Full Text] [Related]
25. Early results of PREDICT study give hope for novel pharmacoprediction model in growth hormone therapy.
Pharmacogenomics; 2008 Nov; 9(11):1581. PubMed ID: 19018711
[No Abstract] [Full Text] [Related]
26. Association of Turner Syndrome and Growth Hormone Deficiency: A Review.
Marques JS; Aires S
Pediatr Endocrinol Rev; 2015 Sep; 13(1):455-7. PubMed ID: 26540761
[TBL] [Abstract][Full Text] [Related]
27. Current practice in diagnosis and treatment of growth hormone deficiency in childhood: a survey from Turkey.
Poyrazoğlu Ş; Akçay T; Arslanoğlu İ; Atabek ME; Atay Z; Berberoğlu M; Bereket A; Bideci A; Bircan İ; Böber E; Can Ş; Cesur Y; Darcan Ş; Demir K; Dündar B; Ersoy B; Esen İ; Güven A; Kara C; Keskin M; Kurtoğlu S; Memioğlu N; Özbek MN; Özgen T; Sarı E; Şıklar Z; Şimşek E; Turan S; Yeşilkaya E; Yüksel B; Darendeliler F
J Clin Res Pediatr Endocrinol; 2015 Mar; 7(1):37-44. PubMed ID: 25800474
[TBL] [Abstract][Full Text] [Related]
28. Implications of a data-driven approach to treatment with growth hormone in children with growth hormone deficiency and Turner syndrome.
Kaspers S; Ranke MB; Han D; Loftus J; Wollmann H; Lindberg A; Roelants M; Kleintjens J
Appl Health Econ Health Policy; 2013 Jun; 11(3):237-49. PubMed ID: 23649890
[TBL] [Abstract][Full Text] [Related]
29. A pilot study to evaluate gene expression profiles in peripheral blood mononuclear cells (PBMCs) from children with GH deficiency and Turner syndrome in response to GH treatment.
Whatmore AJ; Patel L; Clayton PE
Clin Endocrinol (Oxf); 2009 Mar; 70(3):429-34. PubMed ID: 19018778
[TBL] [Abstract][Full Text] [Related]
30. Growth hormone receptor exon 3 isoforms and their implication in growth disorders and treatment.
Jorge AA; Arnhold IJ
Horm Res; 2009 Apr; 71 Suppl 2():55-63. PubMed ID: 19407498
[TBL] [Abstract][Full Text] [Related]
31. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth?
Seminara S; Stagi S; Candura L; Scrivano M; Lenzi L; Nanni L; Pagliai F; Chiarelli F
Horm Metab Res; 2005 Dec; 37(12):751-6. PubMed ID: 16372229
[TBL] [Abstract][Full Text] [Related]
32. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
[TBL] [Abstract][Full Text] [Related]
33. The in vitro functional analysis of single-nucleotide polymorphisms associated with growth hormone (GH) response in children with GH deficiency.
De Leonibus C; Murray P; Garner T; Hanson D; Clayton P; Stevens A
Pharmacogenomics J; 2019 Apr; 19(2):200-210. PubMed ID: 29855605
[TBL] [Abstract][Full Text] [Related]
34. The -202 A allele of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP-3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency.
Costalonga EF; Antonini SR; Guerra-Junior G; Mendonca BB; Arnhold IJ; Jorge AA
J Clin Endocrinol Metab; 2009 Feb; 94(2):588-95. PubMed ID: 18984657
[TBL] [Abstract][Full Text] [Related]
35. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
36. Differences in serum GH cut-off values for pharmacological tests of GH secretion depend on the serum GH method. Clinical validation from the growth velocity score during the first year of treatment.
Chaler EA; Rivarola MA; Guerci B; Ciaccio M; Costanzo M; Travaglino P; Maceiras M; Pagani S; Meazza C; Bozzola E; Barberi S; Bozzola M; Belgorosky A
Horm Res; 2006; 66(5):231-5. PubMed ID: 16912509
[TBL] [Abstract][Full Text] [Related]
37. Secondary IGF-I deficiency as a prognostic factor of growth hormone (GH) therapy effectiveness in children with isolated, non-acquired GH deficiency.
Smyczyńska J; Stawerska R; Hilczer M; Lewiński A
Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):209-14. PubMed ID: 25607339
[TBL] [Abstract][Full Text] [Related]
38. The DATAC study: a new growth database. Description of the epidemiology, diagnosis and therapeutic attitude in a group of Spanish children with short stature.
Rodríguez Arnao MD; Sánchez AR; García-Rey C; Arroyo Díez FJ; Estrada RC; Cuartero BG; Merillas MA; López-Siguero JP;
J Pediatr Endocrinol Metab; 2014 Nov; 27(11-12):1201-8. PubMed ID: 25210749
[TBL] [Abstract][Full Text] [Related]
39. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
Colmenares A; González L; Gunczler P; Lanes R
J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
[TBL] [Abstract][Full Text] [Related]
40. Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency.
Jorge AA; Marchisotti FG; Montenegro LR; Carvalho LR; Mendonca BB; Arnhold IJ
J Clin Endocrinol Metab; 2006 Mar; 91(3):1076-80. PubMed ID: 16291702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
